Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jazz Pharma Plc (NQ: JAZZ )

108.08 -1.75 (-1.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 677,809
Open 109.62
Bid (Size) 107.05 (1)
Ask (Size) 112.00 (1)
Prev. Close 109.83
Today's Range 107.53 - 109.66
52wk Range 103.01 - 146.70
Shares Outstanding 62,311,104
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Cannabis Stocks That Could Make Your Grandchildren Rich
These cannabis stocks offer long-term growth potential anchored by solid operational models and diversified revenue streams today. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?
Jazz Pharmaceuticals announced Phase 2b trial results for suvecaltamide (JZP385) in essential tremor patients, revealing no significant improvements over placebo. 
Via Benzinga

Performance

YTD
-14.85%
-14.85%
1 Month
+2.87%
+2.87%
3 Month
-8.35%
-8.35%
6 Month
-10.68%
-10.68%
1 Year
-13.59%
-13.59%

More News

Read More
Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure
Via Investor's Business Daily
3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition
Via InvestorPlace
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Decoding 12 Analyst Evaluations For Jazz Pharmaceuticals
Via Benzinga
Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews
Via Benzinga
Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views
Via Benzinga
The Analyst Landscape: 12 Takes On Jazz Pharmaceuticals
Via Benzinga
7 Overlooked Stocks Offering Long-Term Stability From the Shadows
Via InvestorPlace
3 Cannabis Stocks to Buy Now: May 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
7 Blue-Chip Stocks to Buy Now: May 2024
Via InvestorPlace
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Via Benzinga
Topics Cannabis
Exposures Cannabis
Demystifying Jazz Pharmaceuticals: Insights From 4 Analyst Reviews
Via Benzinga
3 Cheap Blue-Chip Stocks to Buy Now: May 2024
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Via Benzinga
Topics Cannabis
Exposures Cannabis
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
3 No-Brainer Stocks to Buy With $300 Right Now
Via The Motley Fool
How To Make Your Cannabis Business More Attractive For Investors In 2024: Advice On Financial Health & Innovation
Via Benzinga
Topics Cannabis
Exposures Cannabis
HC Wainwright & Co. Maintains Buy Rating for Jazz Pharmaceuticals: Here's What You Need To Know
Via Benzinga
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
Via InvestorPlace
Time Is Still The Enemy, Says Mom Who Moved Mountains For Her Epileptic Daughter & Still Advocates For Millions Of CBD Users
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.